Stock TRANSCEPT PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Strategies Transcept Pharmaceuticals Inc Nasdaq

Equities

US89354M1062

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Transcept Pharmaceuticals Inc
03-05 Paratek Pharmaceuticals Announces Positive Efficacy Data for Nuzyra® as Post-Exposure Prophylaxis of Inhalational Anthrax, Triggering Additional Procurement Under Barda Project Bioshield Contract CI
01-16 Paratek Pharmaceuticals, Inc. Promotes Jonathan Light to General Counsel, Corporate Secretary and Chief Compliance Officer CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRTK Stock
  4. Stock
  5. News Transcept Pharmaceuticals Inc
  6. MarketScreener Strategies